The use of rituximab to treat a patient with ankylosing spondylitis and hepatitis B.
Rodríguez-Escalera
C
C
Fernández-Nebro
A
A
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006509:Hepatitis B / Q000188:drug therapy* / Q000276:immunology; D006515:Hepatitis B virus; D006801:Humans; D000069283:Rituximab; D013167:Spondylitis, Ankylosing / Q000188:drug therapy* / Q000821:virology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab